A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes

A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term that no longer excludes patients that consume alcohol or present other liver diseases, unlike nonalcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the role of different biomarkers as predictors of M...

Full description

Bibliographic Details
Main Authors: Ion Cristian Efrem, Maria Moța, Ionela Mihaela Vladu, Adina Mitrea, Diana Clenciu, Diana Cristina Protasiewicz Timofticiuc, Ileana-Diana Diaconu, Adina Turcu, Anda Elena Crișan, Cristiana Geormăneanu, Adina Dorina Glodeanu, Beatrice Mahler, Marinela Sînziana Tudor, Anca Maria Amzolini, Simona Elena Micu, Anca Barău Abu Alhija, Adrian Mită, Maria Monalisa Filip, Maria Forțofoiu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Diagnostics
Subjects:
non-alcoholic fatty liver disease
type 2 diabetes
insulin resistance
metabolic dysfunction-associated fatty liver disease
biomarkers
Online Access:https://www.mdpi.com/2075-4418/12/10/2426

Internet

https://www.mdpi.com/2075-4418/12/10/2426

Similar Items